Works by Tumani, H.

Results: 44

CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome.

Published in:

2009

By:

Petzold A;
Brettschneider J;
Jin K;
Keir G;
Murray NM;
Hirsch NP;
Itoyama Y;
Reilly MM;
Takeda A;
Tumani H;
Petzold, A;
Brettschneider, J;
Jin, K;
Keir, G;
Murray, N M F;
Hirsch, N P;
Itoyama, Y;
Reilly, M M;
Takeda, A;
Tumani, H

Publication type:

journal article

Interferon- β1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.

Published in:

Acta Neurologica Scandinavica, 2006, v. 114, n. 6, p. 368, doi. 10.1111/j.1600-0404.2006.00700.x

By:

Dressel, A.;
Kolb, A. K.;
Elitok, E.;
Bitsch, A.;
Bogumil, T.;
Kitze, B.;
Tumani, H.;
Weber, F.

Publication type:

Article

Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis.

Published in:

Acta Neurologica Scandinavica, 2004, v. 110, n. 6, p. 386, doi. 10.1111/j.1600-0404.2004.00347.x

By:

Bitsch, A.;
Bahner, D.;
Wachter, C.;
Elitok, E.;
Bogumil, T.;
Dressel, A.;
Polak, T.;
Tumani, H.;
Weber, F.;
Poser, S.;
Kitze, B.

Publication type:

Article

Natalizumab-associated cerebellar PML: a case report on how to slow down IRIS.

Published in:

2015

By:

Lauda, F.;
Fangerau, T.;
Javaheripour-Otto, K.;
Pinkhardt, E.;
Kassubek, J.;
Tumani, H.

Publication type:

Letter

Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica.

Published in:

2013

By:

Jarius, S.;
Lauda, F.;
Wildemann, B.;
Tumani, H.

Publication type:

Letter

Central inflammation versus peripheral regulation in multiple sclerosis.

Published in:

Journal of Neurology, 2011, v. 258, n. 8, p. 1518, doi. 10.1007/s00415-011-5973-5

By:

Edwards, L. J.;
Sharrack, B.;
Ismail, A.;
Tumani, H.;
Constantinescu, C. S.

Publication type:

Article

Diagnosis of cerebral toxoplasmosis by detection of Toxoplasma gondii tachyzoites in cerebrospinal fluid.

Published in:

Journal of Neurology, 2008, v. 255, n. 6, p. 939, doi. 10.1007/s00415-008-0691-3

By:

Palm, C.;
Tumani, H.;
Pietzcker, T.;
Bengel, D.

Publication type:

Article

Gender-specificities in Alzheimer's disease and mild cognitive impairment.

Published in:

Journal of Neurology, 2008, v. 255, n. 1, p. 117, doi. 10.1007/s00415-008-0726-9

By:

Beinhoff, U.;
Tumani, H.;
Brettschneider, J.;
Bittner, D.;
Riepe, M.

Publication type:

Article

Patientin mit organischem Psychosyndrom und neurologischen Herdzeichen unter Immunsuppression.

Published in:

Der Internist, 2008, v. 49, n. 1, p. 101, doi. 10.1007/s00108-007-1983-x

By:

Kühnlein, P.;
Ringhoffer, M.;
Tumani, H.;
Gdynia, H.J.

Publication type:

Article

Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Published in:

Annals of Neurology, 1995, v. 37, n. 1, p. 82, doi. 10.1002/ana.410370115

By:

Rieckmann, P.;
Albrecht, M.;
Kitze, B.;
Weber, T.;
Tumani, H.;
Broocks, A.;
Lüer, W.;
Helwig, A.;
Poser, S.

Publication type:

Article

Chemical analysis of cerebrospinal fluid leakage.

Published in:

2007

By:

Scheithauer M;
Wick M;
Tumani H

Publication type:

Journal Article

Brain specific proteins in cerebrospinal fluid (CSF): factors influencing their concentration in CSF and clinical relevance.

Published in:

2005

By:

Tumani H;
Brettschneider J

Publication type:

Journal Article

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis.

Published in:

2019

By:

Abdelhak, A.;
Huss, A.;
Kassubek, J.;
Tumani, H.;
Otto, M.

Publication type:

Correction Notice

6-sulpho LacNAc<sup>+</sup> dendritic cells accumulate in various inflammatory, but not ischaemic conditions of the central nervous system.

Published in:

Neuropathology & Applied Neurobiology, 2016, v. 42, n. 4, p. 394, doi. 10.1111/nan.12313

By:

Thomas, K.;
Metz, I.;
Tumani, H.;
Brück, W.;
Ziemssen, T.

Publication type:

Article

Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 9, p. 1209, doi. 10.1177/1352458512463483

By:

Harrer, A;
Tumani, H;
Niendorf, S;
Lauda, F;
Geis, C;
Weishaupt, A;
Kleinschnitz, C;
Rauer, S;
Kuhle, J;
Stangel, M;
Weber, F;
Uhr, M;
Linnebank, M;
Wildemann, B;
Jarius, S;
Guger, M;
Ayzenberg, I;
Chan, A;
Zettl, U;
Wiendl, H

Publication type:

Article

Liquordiagnostik bei Multipler Sklerose.

Published in:

Der Nervenarzt, 2016, v. 87, n. 12, p. 1282, doi. 10.1007/s00115-016-0220-z

By:

Ruprecht, K.;
Tumani, H.

Publication type:

Article

Strategien der Liquorbefundung - integrierter Befundbericht.

Published in:

Der Nervenarzt, 2016, v. 87, n. 12, p. 1271, doi. 10.1007/s00115-016-0232-8

By:

Uhr, M.;
Tumani, H.;
Lange, P.

Publication type:

Article

Stellenwert der Liquordiagnostik bei neuropsychiatrischen Erkrankungen.

Published in:

2016

By:

Tumani, H.;
Uhr, M.;
Wildemann, B.;
Wick, M.

Publication type:

Editorial

Aktuelles zur Therapieumstellung bei Multipler Sklerose.

Published in:

Der Nervenarzt, 2015, v. 86, n. 10, p. 1236, doi. 10.1007/s00115-015-4368-8

By:

Kolber, P.;
Luessi, F.;
Meuth, S.G.;
Klotz, L.;
Korn, T.;
Trebst, C.;
Tackenberg, B.;
Kieseier, B.;
Kümpfel, T.;
Fleischer, V.;
Tumani, H.;
Wildemann, B.;
Lang, M.;
Flachenecker, P.;
Meier, U.;
Brück, W.;
Limmroth, V.;
Haghikia, A.;
Hartung, H.-P.;
Stangel, M.

Publication type:

Article

CXCL13 als Biomarker der akuten Neuroborreliose.

Published in:

Der Nervenarzt, 2014, v. 85, n. 4, p. 459, doi. 10.1007/s00115-014-4020-z

By:

Rupprecht, T.A.;
Lechner, C.;
Tumani, H.;
Fingerle, V.

Publication type:

Article

Aktuelle Liquordiagnostik bei erregerbedingten Krankheiten.

Published in:

Der Nervenarzt, 2013, v. 84, n. 2, p. 229, doi. 10.1007/s00115-012-3701-8

By:

Süssmuth, S.D.;
Brettschneider, J.;
Spreer, A.;
Wick, M.;
Jesse, S.;
Lewerenz, J.;
Otto, M.;
Tumani, H.

Publication type:

Article

Proteinbiomarker im Liquor.

Published in:

2010

By:

Tumani, H.;
Lehmensiek, V.;
Süssmuth, S. D.;
Brettschneider, J.

Publication type:

Abstract

Liquordiagnostik bei CT-negativer Subarachnoidalblutung.

Published in:

Der Nervenarzt, 2010, v. 81, n. 8, p. 973, doi. 10.1007/s00115-010-2997-5

By:

Tumani, H.;
Petzold, A.;
Wick, M.;
Kühn, H.-J.;
Uhr, M.;
Otto, M.;
Regeniter, A.;
Brettschneider, J.

Publication type:

Article

The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.

Published in:

2006

By:

Brettschneider J;
Petzold A;
Schöttle D;
Claus A;
Riepe M;
Tumani H

Publication type:

Journal Article

Serum GFAP as a biomarker for disease severity in multiple sclerosis.

Published in:

Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33158-8

By:

Abdelhak, A.;
Huss, A.;
Kassubek, J.;
Tumani, H.;
Otto, M.

Publication type:

Article

Expression of the beta-trace protein in human pachymeninx as revealed by in situ hybridization and immunocytochemistry.

Published in:

Journal of Neuroscience Research, 1999, v. 57, n. 5, p. 730, doi. 10.1002/(SICI)1097-4547(19990901)57:5<730::AID-JNR14>3.0.CO;2-7

By:

Blödorn, B.;
Brück, W.;
Tumani, H.;
Michel, U.;
Rieckmann, P.;
Althans, N.;
Mäder, M.

Publication type:

Article

Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients.

Published in:

Molecular Diagnosis & Therapy, 2014, v. 18, n. 6, p. 631, doi. 10.1007/s40291-014-0114-3

By:

Rommer, P.;
Kamin, F.;
Petzold, A.;
Tumani, H.;
Abu-Mugheisib, M.;
Koehler, W.;
Hoffmann, F.;
Winkelmann, A.;
Benecke, R.;
Zettl, U.

Publication type:

Article

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.

Published in:

Fluids & Barriers of the CNS, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12987-015-0008-8

By:

Dersch, R.;
Hottenrott, T.;
Senel, M.;
Lehmensiek, V.;
Tumani, H.;
Rauer, S.;
Stich, O.

Publication type:

Article

Applying New Research Criteria for Diagnosis of Early Alzheimer's Disease: Sex and Intelligence Matter.

Published in:

International Journal of Alzheimer's Disease, 2009, v. 2009, p. 1, doi. 10.4061/2009/638145

By:

Beinhoff, U.;
Tumani, H.;
Riepe, M. W.

Publication type:

Article

Intrathecal immunoglobulin synthesis in patients with symptomatic epilepsy and epilepsy of unknown etiology ('cryptogenic').

Published in:

European Journal of Neurology, 2017, v. 24, n. 9, p. 1188, doi. 10.1111/ene.13348

By:

Fauser, S.;
Soellner, C.;
Bien, C. G.;
Tumani, H.

Publication type:

Article

Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis.

Published in:

European Journal of Neurology, 2013, v. 20, n. 8, p. 1170, doi. 10.1111/ene.12146

By:

Roth, N. M.;
Saidha, S.;
Zimmermann, H.;
Brandt, A. U.;
Oberwahrenbrock, T.;
Maragakis, N. J.;
Tumani, H.;
Ludolph, A. C.;
Meyer, T.;
Calabresi, P. A.;
Paul, F.

Publication type:

Article

A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer’s disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF.

Published in:

European Journal of Neurology, 2010, v. 17, n. 4, p. 631, doi. 10.1111/j.1468-1331.2009.02810.x

By:

Uttner, I.;
Kirchheiner, J.;
Tumani, H.;
Mottaghy, F. M.;
Lebedeva, E.;
Özer, E.;
Ludolph, A. C.;
Huber, R.;
von Arnim, C. A. F.

Publication type:

Article

EFNS guidelines on disease-specific CSF investigations.

Published in:

European Journal of Neurology, 2009, v. 16, n. 6, p. 760, doi. 10.1111/j.1468-1331.2009.02595.x

By:

Deisenhammer, F.;
Egg, R.;
Giovannoni, G.;
Hemmer, B.;
Petzold, A.;
Sellebjerg, F.;
Teunissen, C.;
Tumani, H.

Publication type:

Article

MxA protein – an interferon beta biomarker in primary progressive multiple sclerosis patients.

Published in:

European Journal of Neurology, 2008, v. 15, n. 8, p. 822, doi. 10.1111/j.1468-1331.2008.02190.x

By:

Millonig, A.;
Dressel, A.;
Bahner, D.;
Bitsch, A.;
Bogumil, T.;
Elitok, E.;
Kitze, B.;
Tumani, H.;
Weber, F.;
Gneiss, C.;
Deisenhammer, F.

Publication type:

Article

Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rRNA gene sequence.

Published in:

European Journal of Neurology, 2007, v. 14, n. 9, p. 1067, doi. 10.1111/j.1468-1331.2007.01878.x

By:

Bengel, D.;
Susa, M.;
Schreiber, H.;
Ludolph, A. C.;
Tumani, H.

Publication type:

Article

Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 2, p. 129, doi. 10.1177/1352458509356368

By:

Teunissen, C. E.;
Tumani, H. T.;
Bennett, J. L.;
Berven, F. S.;
Brundin, L.;
Comabella, M.;
Franciotta, D.;
Federiksen, J. L.;
Fleming, J. O.;
Furlan, R.;
Hintzen, R. Q.;
Hughes, S. G.;
Johnson, M. H.;
Krasulova, E.;
Kuhle, J.;
Magnone, Maria-Chiara;
Petzold, A.;
Rajda, C.;
Rejdak, K.;
Schmidt, H. K.

Publication type:

Article

Cerebrospinal fluid proteome profile in multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2007, v. 13, n. 7, p. 840, doi. 10.1177/1352458507076406

By:

Lehmensiek, V.;
Süssmuth, S. D.;
Tauscher, G.;
Brettschneider, J.;
Felk, S.;
Gillardon, F.;
Tumani, H.

Publication type:

Article

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2005, v. 11, n. 3, p. 261, doi. 10.1191/1352458505ms1159oa

By:

Brettschneider, J.;
Maier, M.;
Arda, S.;
Claus, A.;
Süssmuth, S. D.;
Kassubek, J.;
Tumani, H.

Publication type:

Article

Narcolepsy.

Published in:

Journal of Neurology, 2005, v. 252, n. 11, p. 1372, doi. 10.1007/s00415-005-0870-4

By:

Jordan, W.;
Tumani, H.;
Cohrs, S.;
Rodenbeck, A.;
Rüther, E.;
Bechthold, J.;
Mayer, G.

Publication type:

Article

P03-76 - Mild encephalitis inflammation subgroups in affective and schizophrenic disorders

Published in:

2010

By:

Bechter, K.;
Reiber, H.;
Herzog, S.;
Fuchs, D.;
Tumani, H.;
Maxeiner, H.G.

Publication type:

Abstract

P03-61 - Characteristic CSF and peripheral blood cytokine levels in neurological and psychiatric patients

Published in:

2010

By:

Maxeiner, H.G.;
Kurfiss, S.;
Brettschneider, J.;
Bechter, K.;
Lehmensiek, V.;
Tumani, H.

Publication type:

Abstract

Impact of serum storage conditions on microRNA stability.

Published in:

Leukemia (08876924), 2012, v. 26, n. 11, p. 2414, doi. 10.1038/leu.2012.106

By:

Grasedieck, S;
Schöler, N;
Bommer, M;
Niess, J H;
Tumani, H;
Rouhi, A;
Bloehdorn, J;
Liebisch, P;
Mertens, D;
Döhner, H;
Buske, C;
Langer, C;
Kuchenbauer, Florian

Publication type:

Article

CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome.

Published in:

Muscle & Nerve, 2009, v. 40, n. 1, p. 42, doi. 10.1002/mus.21239

By:

Petzold, A.;
Brettschneider, J.;
Jin, K.;
Keir, G.;
Murray, N.M.F.;
Hirsch, N.P.;
Itoyama, Y.;
Reilly, M.M.;
Takeda, A.;
Tumani, H.

Publication type:

Article

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Published in:

2018

By:

Jarius, S.;
Ruprecht, K.;
Stellmann, J. P.;
Huss, A.;
Ayzenberg, I.;
Willing, A.;
Trebst, C.;
Pawlitzki, M.;
Abdelhak, A.;
Grüter, T.;
Leypoldt, F.;
Haas, J.;
Kleiter, I.;
Tumani, H.;
Fechner, K.;
Reindl, M.;
Paul, F.;
Wildemann, B.;
Grüter, T

Publication type:

journal article